Sativa Wellness, (AQSE:SWEL)(CSE:SWEL) has started trading in London, on the Aquis Exchange, and in Canada following its merger with Stillcanna Inc.
The group said it is now a fully integrated European seed-to-consumer CBD business, employing extraction and formulation experts and experienced hemp cultivators with laboratory testing capabilities.
“The merger brings together expertise that cover all stages of the product development lifecycle, from seed through to cultivation and extraction, and now testing, bottling and distribution," it said in a statement.
Henry Lees-Buckley, Sativa Wellness's chief executive, added: "We are thrilled to have completed the process of combining our two businesses to form a leading European CBD Wellness company.
“Discerning consumers demand very high quality and compliant products and we believe the best way to ensure the company is able to fulfil this demand is to have management control throughout the entire production, manufacturing and distribution process.
“The regulatory environment in the UK and Europe are also rightly demanding companies achieve new compliance standards such as the UK FSA Novel Foods accreditation.
“We expect our products will be validated by the UK FSA by the March 2021 deadline," Lees-Buckley added.
Shares were quoted on Aquis at 5.5p in early trading.